Kalua T, Tippett Barr BA, van Oosterhout JJ, Mbori-Ngacha D, Schouten EJ, Gupta S, Sande A, Zomba G, Tweya H, Lungu E, Kajoka D, Tih P, Jahn A.J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S43-S50. doi: 10.1097/QAI.0000000000001326. Review. PubMed PMID: 28398996.

Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, Fox MP, Wood R, Prozesky H, Giddy J, Garone DB, Cornell M, Egger M, Boulle A. (2013)PLoS Med 10(4):e1001418. doi: 10.1371/journal.pmed.1001418

McCarthy E, Joseph J, Foster G, Mangwiro AZ, Mwapasa V, Oyeledun B, Phiri S, Sam-Agudu NA, Essajee S. J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S233-S239. doi: 10.1097/QAI.0000000000001364. PubMed PMID: 28498194; PubMed Central PMCID: PMC5432093.

Vorkas CK, Tweya H, Mzinganjira D, Dickie G, Weigel R, Phiri S, Hosseinipour M. (2012) Tropical Medicine & International Health 17(2):169-176

Gadabu, O.J.; Munthali, C.V.; Zachariah, R.; Gudmund-Hinderaker, S.; Jahn, A.; Tweya, H.; Gondwe, A.; Mumba, S.; Lungu, M.; Malisita, K.; Mhango, E.; Makombe, S.D.; Tenthani, L.; Mwalwanda, L.; Moyo, C.; Douglas, G.P.; Lewis, Z.L.; Chimbwandira, F. Is transcription of data on antiretroviral treatment from electronic to paper-based registers reliable in Malawi? , Volume 1, Number 1, September 2011 , pp. 10-12(3) Van Lettow, M.; Chan, A.K.; Ginsburg, A.S.; Tweya, H.; Gareta, D.; Njala, J.; Kanyerere, H.; Phiri, S.; Idana, I. Timing and uptake of ART during treatment for active tuberculosis in HIV co-infected adults in Malawi. Public Health Action, Volume 1, Number 1, September 2011 , pp. 6-9(4)

Kalua T, Tippett Barr BA, van Oosterhout JJ, Mbori-Ngacha D, Schouten EJ, Gupta S, Sande A, Zomba G, Tweya H, Lungu E, Kajoka D, Tih P, Jahn A. J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S43-S50. doi: 10.1097/QAI.0000000000001326. Review. PubMed PMID: 28398996.

Wesevich A, Mtande T, Saidi F, Cromwell E, Tweya H, Hosseinipour MC, Hoffman I, Miller WC, Rosenberg NE. AIDS Care. 2017 Mar 29:1-9. doi: 10.1080/09540121.2017.1308464. [Epub ahead of print] PubMed PMID: 28355926.

Tweya H, Feldacker C, Ben-Smith A, Harries AD, Komatsu R, Jahn A, Phiri S, Tassie J. (2012) BMC Health Services Research, July 20, 2012, Vol.12, p.210

Glaser N, Phiri S, Bruckner T, Nsona D, Tweya H, Ahrenshop N, Neuhann F.BMC Nephrol. 2016 Nov 22;17(1):186. PubMed PMID: 27875991; PubMed Central PMCID: PMC5118906.

Cataldo F, Sam-Agudu NA, Phiri S, Shumba B, Cornelius LJ, Foster G. J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S224-S232. doi: 10.1097/QAI.0000000000001375. PubMed PMID: 28498193.

Description

Ultrasound is increasingly used in point-of-care applications and has great potential to support the diagnosis of infectious diseases, especially in resource-limited settings. A cross-sectional study was performed involving 100 Malawian patients with a clinical indication for ultrasound. Furthermore, the literature on point-of-care ultrasound (POCUS) in Sub-Saharan Africa was reviewed to establish its applicability, most frequent indications, findings, and implications for treatment, and therefore relevance in POCUS curricula, with a main focus on infectious diseases. In Malawi, the main indications for ultrasound were weight loss, abdominal pain, and shortness of breath. Abnormal findings were observed in 77% of patients, the most common being enlarged abdominal lymph nodes (n = 17), pericardial effusion (n = 15), splenic microabscesses (n = 15), and pleural effusion (n = 14). POCUS led to a change in treatment in 72% of patients. The literature on the various POCUS applications used in Malawi was reviewed, including focused assessment with sonography for HIV-associated TB (FASH), heart, liver, kidney, deep venous thrombosis (DVT), and gynaecology. Based on disease prevalence, impact of POCUS on treatment, and technical difficulty, it is proposed that FASH, heart, and DVT are the most relevant POCUS applications in comparable Sub-Saharan African settings and should be incorporated in POCUS curricula. 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).

Luebbert J, Tweya H, Phiri S, Chaweza T, Mwafilaso J, Hosseinipour MC, Ramroth H, Schnitzler P, Neuhann F. (2012) Clinical Infectious Diseases, 2012, Vol.55(3), pp.441-448 [Peer Reviewed Journal]

Chomaker M, Egger M, Ndirangu J, Phiri S, Moultrie H, Technau K, Cox V, Giddy J, Chimbetete C, Wood R, Gsponer T, Moore CB, Rabie H, Eley B, Muhe L, Penazzato M, Essajee S, Keiser O, Davies M. (2013) PLoS Med 10(11): e1001555. doi:10.1371/journal.pmed.1001555

Chomaker M, Egger M, Ndirangu J, Phiri S, Moultrie H, Technau K, Cox V, Giddy J, Chimbetete C, Wood R, Gsponer T, Moore CB, Rabie H, Eley B, Muhe L, Penazzato M, Essajee S, Keiser O, Davies M. (2013) PLoS Med 10(11): e1001555. doi:10.1371/journal.pmed.1001555

Feldacker C, Johnson D, Hosseinipour M, Phiri S, Tweya H. PLoS ONE 7(11): e50871. doi:10.1371/journal.pone.0050871

Tweya H, Feldacker C, Ben-Smith A, Weigel R, Boxshall M, Phiri S, Jahn A. Public Health Action. 2012 Dec 2(4).178-8.